| P2093 | author name string | Christopher J Smith | |
| | Brandon Otto | |
| | Mindy X Wang | |
| | Joseph R Grajo | |
| | Michael Feely | |
| P2860 | cites work | Incidental Bilateral Renal Oncocytoma in a Patient with Metastatic Carcinoma of Unknown Primary: a Pitfall on (18)F-FDG PET/CT | Q33704582 |
| | Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report | Q33762689 |
| | Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms | Q34606281 |
| | Diagnostic approach to eosinophilic renal neoplasms | Q35155653 |
| | Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas | Q36177109 |
| | Giant renal oncocytoma: a case report and review of the literature | Q37703402 |
| | Role of FDG PET/CT in imaging of renal lesions | Q37780803 |
| | PET/CT and renal pathology: a blind spot for radiologists? Part 1, primary pathology | Q38028919 |
| | Imaging spectrum of renal oncocytomas: a pictorial review with pathologic correlation. | Q38287530 |
| | Active surveillance is suitable for intermediate term follow-up of renal oncocytoma diagnosed by percutaneous core biopsy | Q38908504 |
| | Usefulness of MDCT to Differentiate Between Renal Cell Carcinoma and Oncocytoma: Development of a Predictive Model. | Q39969015 |
| | Renal oncocytoma displaying intense activity on 18F-FDG PET. | Q46853389 |
| | Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms. | Q48236597 |
| | Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology. | Q51828562 |
| | Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma. | Q53009561 |
| | Renal oncocytoma growth rates before intervention. | Q53165299 |
| | HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies. | Q53594852 |
| | Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography | Q84757529 |
| P433 | issue | 5 | |
| P304 | page(s) | 27-33 | |
| P577 | publication date | 2017-05-31 | |
| P1433 | published in | Journal of radiology case reports | Q27723462 |
| P1476 | title | Oncocytoma: A Differential Consideration for an Incidentally Detected FDG-Avid Renal Mass on PET/CT. | |
| P478 | volume | 11 | |